Breaking News Bar
updated: 3/20/2014 10:51 AM

AbbVie to test Humira for treatment of fingernal psoriasis

hello
Success - Article sent! close
 
PRNewswire

North Chicago-based AbbVie has started testing to evaluate the use of Humira as a treatment for fingernail psoriasis in patients with moderate to severe chronic plaque psoriasis, an area of unmet need.

Currently there are no approved treatments for fingernail psoriasis.

Order Reprint Print Article
 
Interested in reusing this article?
Custom reprints are a powerful and strategic way to share your article with customers, employees and prospects.
The YGS Group provides digital and printed reprint services for Daily Herald. Complete the form to the right and a reprint consultant will contact you to discuss how you can reuse this article.
Need more information about reprints? Visit our Reprints Section for more details.

Contact information ( * required )

Success - request sent close

"Since treatment options are limited, we welcome research that evaluates new options for patients suffering from this disease and are excited to start evaluating adalimumab in this patient population," said Dr. Phoebe Rich, M.D., clinical adjunct professor of dermatology at Oregon Health Sciences University.

Psoriasis is a noncontagious, chronic immune disease that speeds the growth cycle of skin cells and results in thick, scaly areas of skin. Psoriasis can also affect the fingernails causing pitting, discoloration, loosening and irregular contour of the fingernail. Although the prevalence of fingernail psoriasis in those with moderate to severe chronic plaque psoriasis is unknown, about 50 percent of the 125 million people worldwide with psoriasis have nail involvement.

Humira is currently originally developed for the treatment of rheumatoid arthritis in adults, but has erecently been expanded to treat moderate to severe ulcerative colitis and moderate to severe chronic plaque psoriasis.

Share this page
Comments ()
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked. If a comment violates these standards or our terms of service, click the X in the upper right corner of the comment box. To find our more, read our FAQ.